Velindre Nhs Trust

This study is testing whether adding a new oral drug called AZD5363 to a standard hormone therapy (fulvestrant) can better control advanced breast cancer. It is for postmenopausal women whose cancer has grown despite prior hormone-blocking treatments. The goal is to see if this c…